NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









OKG Capital

OKG Capital

Overview

OKG Capital is an investment fund and venture capital firm that specializes in early-stage Med-Tech and Life Science companies. The firm is committed to supporting high-impact companies with strong social value, with a focus on chronic disease therapeutics and diagnostics, particularly in oncology. It primarily invests in Seed and Series A rounds in Europe and the United States. Its portfolio includes companies in drug discovery, advanced medical imaging, molecular diagnostics, and remote patient monitoring.

Portfolio Companies

6

Investments

OKG Capital investments
CompanyDateStageLead
iFAST DiagnosticsMay 2026Early FundingCo-investor
Oxford Cancer AnalyticsJan 2025Series ACo-investor
iQure PharmaJan 2025Series BCo-investor
52NorthDec 2024SeedCo-investor
DeepLook MedicalSep 2024Series ACo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

Headquarters
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.